Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
AAO, Academy, accentuate, ALA, alpha, arisen, ASC, ASGCT, ASU, bar, barring, Belgium, BIOSECURE, bluebird, Carolina, Chun, citing, CODM, Columbia, complementary, cosibelimab, CPUO, cure, Dang, deficit, delist, disfavored, EHA, enriched, enrichment, Galderma, genuine, Georgia, IASLC, impermissible, imputation, intake, IX, jason, KIPO, Klinge, Lichen, Ligation, maker, malware, MASH, median, metric, mibavademab, Michigan, misconduct, moiety, nezastomig, NMPA, North, numerical, obesity, OD, Ordspono, orthostatic, otoferlin, Pavblu, pendency, Pharm, phishing, pitofsky, pJIA, Polyarticular, Postural, precursor, preemptive, protectionist, QUASAR, Rapirosiran, Regenerative, retaliatory, RMAT, Sam, Sandoz, Saratoga, simplex, situated, smoldering, spun, sublease, subunit, sued, tachycardia, tender, tendered, tirzepatide, town, Truveta, Ulcerative, unjust, unjustly, Unloxcyt, UnloxcytTM, upper, Washington, wasted
Removed:
add, Agonist, Apotex, ballot, BARDA, baricitinib, Biomedical, building, capitalization, CCPA, certiorari, chair, cholesterol, chosen, clear, closing, Commissioner, comprising, compromise, conjugate, consisted, cooperating, Corectim, council, CPPA, CPRA, crisaborole, customary, default, DEI, delgocitinib, demographic, disclaimer, dismissal, economically, emergency, en, enablement, enacting, entering, EUA, fasinumab, feet, flexible, foster, fulfil, governed, growing, HDL, heightened, Helsinki, hemophilia, hired, hour, hundred, importance, indemnity, inform, inhibiting, inhibition, institute, instituted, instituting, institution, interference, invalidity, invention, inventive, IOI, join, jointly, judge, jurisdictional, landry, LDL, leaseback, LEPR, lipase, lipid, lipoprotein, misled, Mitsubishi, modeled, moderate, MTPC, notify, occurring, Olumiant, overexpressing, overturned, pcJIA, petition, PHI, plasma, practical, prepared, prescribed, promulgating, redeemed, regimen, regulating, regulator, rehearing, reimbursing, resident, reversal, River, Road, robert, ruled, ruling, satisfied, sensitivity, suit, supplied, Switzerland, Tanabe, TBA, telephone, Tobacco, topical, transferring, transitional, transmit, turnover, unknown, urticaria, variant, volume, whichever, writ
Filing tables
Filing exhibits
- 10-K Annual report
- 4.1 Description of Securities
- 10.8 Amendment Agreement, Dated December 30, 2014 Between Bayer and Registrant
- 19.1 Insider Trading Policy
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Rule 13A-14(A)
- 32 Certification of CEO and CFO Pursuant to 18 U.s.c. Section 1350
- Download Excel data file
- View Excel data file
Related press release
Associated REGN transcripts
REGN similar filings
Filing view
External links